Readoutin 14d
Sichuan Baili Pharmaceutical Co., Ltd. — BL-B01D1
Phase 3 primary completion: A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type Non-small Cell Lung Cancer(PANKU-Lung02).
- Date
- Dec 2026
- Type
- Readout
- Indication
- Non-small Cell Lung Cancer